BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 27118139)

  • 1. Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.
    Liu H; Zhang G; Huang J; Ma S; Mi K; Cheng J; Zhu Y; Zha X; Huang W
    J Transl Med; 2016 Apr; 14(1):104. PubMed ID: 27118139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway.
    Huang JM; Zhang GN; Shi Y; Zha X; Zhu Y; Wang MM; Lin Q; Wang W; Lu HY; Ma SQ; Cheng J; Deng BF
    Sci Rep; 2014 Jan; 4():3840. PubMed ID: 24452475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD-2/MyD88-mediated NF-κB signaling.
    Ye K; Chen QW; Sun YF; Lin JA; Xu JH
    J Cell Biochem; 2018 Feb; 119(2):1922-1930. PubMed ID: 28815730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-β2GPI/β2GPI stimulates activation of THP-1 cells through TLR4/MD-2/MyD88 and NF-κB signaling pathways.
    Zhou H; Sheng L; Wang H; Xie H; Mu Y; Wang T; Yan J
    Thromb Res; 2013; 132(6):742-9. PubMed ID: 24157085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins.
    Li Z; Block MS; Vierkant RA; Fogarty ZC; Winham SJ; Visscher DW; Kalli KR; Wang C; Goode EL
    Tumour Biol; 2016 Oct; 37(10):13279-13286. PubMed ID: 27460076
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Pan Q; Zhang Q; Chu J; Pais R; Liu S; He C; Eko FO
    Front Cell Infect Microbiol; 2017; 7():514. PubMed ID: 29326885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A3 binds MD-2 to activate p38 and NF-κB pathways in a MyD88-dependent manner.
    Deguchi A; Tomita T; Omori T; Komatsu A; Ohto U; Takahashi S; Tanimura N; Akashi-Takamura S; Miyake K; Maru Y
    J Immunol; 2013 Aug; 191(4):1856-64. PubMed ID: 23858030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
    Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P
    Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury.
    Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J
    Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
    Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
    Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
    Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
    J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing TLR4/MyD88/NF-κB Signaling Pathway Alleviated Inflammation of Corneal Epithelial Cells Infected by ISE.
    Wu L; Du L; Ju Q; Chen Z; Ma Y; Bai T; Ji G; Wu Y; Liu Z; Shao Y; Peng X
    Inflammation; 2021 Apr; 44(2):633-644. PubMed ID: 33174138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Clostridium perfringens type C on TLR4/MyD88/NF-κB signaling pathway in piglet small intestines.
    Shi H; Huang X; Yan Z; Yang Q; Wang P; Li S; Sun W; Gun S
    Microb Pathog; 2019 Oct; 135():103567. PubMed ID: 31163250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways.
    Chen Y; Li H; Li M; Niu S; Wang J; Shao H; Li T; Wang H
    J Ethnopharmacol; 2017 Mar; 200():165-173. PubMed ID: 28232127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginkgolide A inhibits lipopolysaccharide-induced inflammatory response in human coronary artery endothelial cells via downregulation of TLR4-NF-κB signaling through PI3K/Akt pathway.
    Zhaocheng J; Jinfeng L; Luchang Y; Yequan S; Feng L; Kai W
    Pharmazie; 2016 Oct; 71(10):588-591. PubMed ID: 29441927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavonoids from Scutellaria barbata inhibit activation of tumor-associated macrophages by blocking the Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-κB signaling pathway.
    Bao X; Li L; Xue X
    J Tradit Chin Med; 2019 Apr; 39(2):160-165. PubMed ID: 32186037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoids from Radix Tetrastigmae inhibit TLR4/MD-2 mediated JNK and NF-κB pathway with anti-inflammatory properties.
    Liu D; Cao G; Han L; Ye Y; SiMa Y; Ge W
    Cytokine; 2016 Aug; 84():29-36. PubMed ID: 27235587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.
    Szajnik M; Szczepanski MJ; Czystowska M; Elishaev E; Mandapathil M; Nowak-Markwitz E; Spaczynski M; Whiteside TL
    Oncogene; 2009 Dec; 28(49):4353-63. PubMed ID: 19826413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
    Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
    Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide.
    Hassan F; Islam S; Tumurkhuu G; Naiki Y; Koide N; Mori I; Yoshida T; Yokochi T
    BMC Cancer; 2006 Dec; 6():281. PubMed ID: 17156435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.